MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX Study)
-
Enrollment
This study is currently enrolling. -
Associated Conditions
-
Research Area
Clinical Cancer Research -
Location
-
Principal Investigator
-
Sponsor
Agendia, Inc.
The purpose of this study is to create a large-scale, population-based database. This database will match health information with genome data to potentially identify new gene associations in breast cancer. The Agendia Breast Cancer tests include MammaPrint® and BluePrint™, which are tests that help analyze and profile breast cancer tumor.
Enrollment Form
This study is currently enrolling.